Fundraising Fox

H. Martin Seidel

Investor

Advisor at Lightstone Ventures

Boston

About

Advisor supporting the biopharmaceutical team since 2025 and CEO of IFM Therapeutics. He previously served as Global Head of BD&L for the Novartis Institutes for Biomedical Research and led NIBR's Genomics Institute.

Colleagues at Lightstone Ventures

Frequently asked questions

Where does H. Martin Seidel work?
H. Martin Seidel is Advisor at Lightstone Ventures.